Want to see SE:SPEC full AI Analyst Report?
SpectraCure AB (SPEC) Ratios
SpectraCure AB Ratios
SE:SPEC's free cash flow for Q2 2026 was $-4.91M. For the 2026 fiscal year, SE:SPEC's free cash flow was decreased by $-97.00K and operating cash flow was $-4.82M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.52 | 1.93 | 5.55 | 7.96 | 10.59 |
| Quick Ratio | 1.52 | 1.93 | 5.55 | 7.96 | 10.59 |
| Cash Ratio | 1.27 | 1.58 | 5.38 | 7.86 | 10.50 |
| Solvency Ratio | -4.90 | -1.44 | -1.33 | -1.85 | -1.39 |
| Operating Cash Flow Ratio | -2.25 | -1.89 | -1.77 | -1.94 | -1.51 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ 5.31M | $ 8.10M | $ 43.77M | $ 82.22M | $ 115.95M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.03 | 0.04 | 0.05 | 0.02 | 0.03 |
| Debt-to-Equity Ratio | 0.03 | 0.05 | 0.05 | 0.02 | 0.03 |
| Debt-to-Capital Ratio | 0.03 | 0.05 | 0.05 | 0.02 | 0.03 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.12 | 1.13 | 1.12 | 1.08 | 1.08 |
| Debt Service Coverage Ratio | -41.33 | -43.62 | -40.13 | -122.04 | -83.38 |
| Interest Coverage Ratio | -43.34 | -52.32 | -40.90 | -148.23 | -99.66 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.01 | 0.06 | 0.07 | 0.03 | 0.05 |
| Net Debt to EBITDA | 0.20 | 0.64 | 2.40 | 4.06 | 6.11 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 0.00% | -2900.31% | 665.12% | 0.00% |
| EBIT Margin | 0.00% | 0.00% | -6752.83% | -4674.77% | 0.00% |
| EBITDA Margin | 0.00% | 0.00% | -6594.03% | -4130.80% | 0.00% |
| Operating Profit Margin | 0.00% | 0.00% | -6714.15% | -5005.19% | 0.00% |
| Pretax Profit Margin | 0.00% | 0.00% | -6434.59% | -4708.53% | 0.00% |
| Net Profit Margin | 0.00% | 0.00% | -6427.99% | -4698.70% | 0.00% |
| Continuous Operations Profit Margin | 0.00% | 0.00% | -6427.99% | -4708.53% | 0.00% |
| Net Income Per EBT | 100.05% | 99.97% | 99.90% | 99.79% | 99.98% |
| EBT Per EBIT | 103.13% | 93.98% | 95.84% | 94.07% | 95.61% |
| Return on Assets (ROA) | -53.68% | -19.01% | -14.11% | -15.59% | -12.25% |
| Return on Equity (ROE) | -59.95% | -21.53% | -15.74% | -16.85% | -13.29% |
| Return on Capital Employed (ROCE) | -57.95% | -22.37% | -15.90% | -17.92% | -13.70% |
| Return on Invested Capital (ROIC) | -56.40% | -21.85% | -15.62% | -17.60% | -13.52% |
| Return on Tangible Assets | -290.99% | -83.18% | -30.78% | -25.44% | -17.04% |
| Earnings Yield | -87.86% | -9.29% | -5.31% | -5.19% | -4.09% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 1.74 | 0.49 | 0.00 |
| Payables Turnover | 17.63 | 2.94 | 9.20 | -1.89 | -0.76 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | -209319526137856000.00 | 1385000.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.05 | 0.14 | 0.00 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 |
| Cash Conversion Cycle | -20.70 | -124.01 | 170.38 | 938.50 | 481.48 |
| Days of Sales Outstanding | 0.00 | 0.00 | 210.05 | 745.58 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | -0.00 | 0.00 |
| Days of Payables Outstanding | 20.70 | 124.01 | 39.67 | -192.93 | -481.48 |
| Operating Cycle | 0.00 | 0.00 | 210.05 | 745.58 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.06 | -0.22 | -0.19 | -0.24 | -0.19 |
| Free Cash Flow Per Share | -0.11 | -0.38 | -0.35 | -0.34 | -0.28 |
| Dividend Paid and CapEx Coverage Ratio | -1.22 | -1.43 | -1.18 | -2.27 | -2.19 |
| Capital Expenditure Coverage Ratio | -1.22 | -1.43 | -1.18 | -2.27 | -2.19 |
| Operating Cash Flow Coverage Ratio | -7.99 | -4.24 | -2.78 | -8.50 | -3.79 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | -58.74 | -42.60 | 0.00 |
| Free Cash Flow Yield | -68.42% | -14.98% | -8.96% | -6.78% | -4.74% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -1.11 | -10.63 | -18.82 | -19.25 | -24.47 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 1209.57 | 904.64 | 0.00 |
| Price-to-Book (P/B) Ratio | 0.68 | 2.32 | 2.96 | 3.24 | 3.25 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -1.46 | -6.68 | -11.17 | -14.74 | -21.08 |
| Price-to-Operating Cash Flow Ratio | -2.66 | -11.35 | -20.59 | -21.24 | -30.70 |
| Price-to-Earnings Growth (PEG) Ratio | 0.03 | -0.74 | 0.98 | -2.31 | -0.59 |
| Enterprise Value Multiple | -1.03 | -11.49 | -15.95 | -17.84 | -21.84 |
| Enterprise Value | 53.31M | 234.56M | 334.41M | 397.12M | 446.34M |
| EV to EBITDA | -1.03 | -11.49 | -15.95 | -17.84 | -21.84 |
| EV to Sales | 0.00 | 0.00 | 1051.60 | 736.77 | 0.00 |
| EV to Free Cash Flow | -1.22 | -6.32 | -9.71 | -12.01 | -16.47 |
| EV to Operating Cash Flow | -2.22 | -10.75 | -17.90 | -17.29 | -23.99 |
| Tangible Book Value Per Share | 0.02 | 0.14 | 0.53 | 0.90 | 1.26 |
| Shareholders’ Equity Per Share | 0.23 | 1.10 | 1.34 | 1.55 | 1.81 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 |
| Net Income Per Share | -0.14 | -0.24 | -0.21 | -0.26 | -0.24 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.03 | 1.00 | 0.95 | 1.01 | 1.01 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 21.56 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.43 | 0.95 | 0.91 | 0.90 | 0.80 |
Currency in SEK
